About Saiseikai Yokohamashi Tobu Hospital
社会福祉法人 恩賜財団 済生会支部神奈川県済生会横浜市東部病院は、神奈川県横浜市鶴見区にある医療機関である。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Saiseikai Yokohamashi Tobu Hospital
During the past decade, Saiseikai Yokohamashi Tobu Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 12 clinical trials were completed, i.e. on
average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saiseikai Yokohamashi Tobu Hospital" #1 sponsor was "Boston Scientific Corporation" with 8 trials, followed by "Abbott Medical Devices" with 4 trials
sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Alexion"
with 2 trials sponsored. Other sponsors include 9 different institutions and
companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saiseikai Yokohamashi Tobu Hospital"
#1 collaborator was "Abbott" with 1 trials as a collaborator, "Association for Establishment of Ebvidence in Interventions" with 1 trials as a collaborator, "CardioVascular Research Foundation, Korea" with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Saiseikai Yokohamashi Tobu Hospital
According to Clinical.Site data, the most researched conditions in "Saiseikai Yokohamashi Tobu Hospital" are
"Coronary Artery Disease" (12 trials), "Myocardial Ischemia" (3 trials), "Atherosclerosis" (2 trials), "Coronary Artery Stenosis" (2 trials) and "Coronary Disease" (2 trials). Many other conditions were trialed in "Saiseikai Yokohamashi Tobu Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Saiseikai Yokohamashi Tobu Hospital
Most popular intervention types in "Saiseikai Yokohamashi Tobu Hospital" are "Device" (21 trials), "Drug" (12 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin" (2 trials), "TAK-625" (2 trials), "Thienopyridine" (2 trials), "3 months of dual antiplatelet therapy (DAPT)" (1 trials) and "ABSORB BVS" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saiseikai Yokohamashi Tobu Hospital
The vast majority of trials in "Saiseikai Yokohamashi Tobu Hospital" are
31 trials for "All" genders.
Clinical Trials Status at Saiseikai Yokohamashi Tobu Hospital
Currently, there are NaN active trials in "Saiseikai Yokohamashi Tobu Hospital".
undefined are not yet recruiting,
3 are recruiting,
7 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Saiseikai Yokohamashi Tobu Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Saiseikai Yokohamashi Tobu Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 13 trials that are defined as “Not Applicable".